Antibody Contamination Contract Manufacturing Hormones 
Roots Analysis
OCTOBER 24, 2023
This has led to their widespread production and extensive use in the treatment of various indications including hormonal imbalances, oncological disorders and respiratory disorders. Antibody-Drug Conjugates: ADCs are monoclonal antibodies (mAbs) attached to surface antigens by chemical or a liable linker.
The Pharma Data
MAY 4, 2021
Biosimilars, which grew 79% operationally to $530 million, primarily driven by recent oncology monoclonal antibody biosimilar launches of Ruxience (rituximab), Zirabev (bevacizumab) and Trazimera (trastuzumab) globally, as well as continued growth from Retacrit (epoetin) in the U.S.; Hospital products, which grew 10% operationally to $2.3
Expert insights. Personalized for you.
40 
Let's personalize your content